Belgium· BE-AMP-SAM432397-00
Nexobrid 2 g
A bromelains product containing proteolytic enzymes concentrate enriched in bromelain, registered in Belgium by Mediwound Germany. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Bromelains is registered in 11 of 19 countries.
Countries holding a registration under ATC D03BA03 (bromelains), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Bromelains · ATC D03BA03
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Proteolytic Enzymes Concentrate Enriched in Bromelain
- Manufacturer
- Mediwound Germany
- Country
- Belgium (BE)
- ATC code
- D03BA03
- ATC class
- Bromelains
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7714959
- be_apb3237559
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bromelains in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEXOBRIDMediWound Germany GmbH, Rüsselsheim
- SpainNEXOBRID 2 g polvo y gel para gelMediwound Germany Gmbh
- SwedenNexoBrid 2 g Pulver och gel till gelMediWound Germany GmbH
- GermanyBromelain-PosUrsapharm Arzneimittel Gmbh
- United KingdomBackOsamine tabletsOptima Consumer Health Ltd
- PolandNexoBridMediWound Germany GmbH
- NorwayNexoBridMediWound Germany GmbH
- SwitzerlandNexoBrid, poudre et gel pour gelTriskel INTEGRATED SERVICES SA
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Bromelain-Pos, Bromelaintabletten Hysan
- Iceland · Nexobrid
- Liechtenstein · Nexobrid
- Norway · Nexobrid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08d31ece-1239-4032-9fd2-10735ef33d5c GET /v1/drugs/08d31ece-1239-4032-9fd2-10735ef33d5c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and gel for gel",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Nexobrid 2 g",
"name_fr": "Nexobrid 2 g",
"name_nl": "Nexobrid 2 g",
"amp_code": "SAM432397-00",
"strengths": [
"90.0000"
],
"pack_count": 1,
"substances": [
"Proteolytic Enzymes Concentrate Enriched in Bromelain",
"Disodium Hydrogen Phosphate",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Bromelains",
"authorisation_numbers": [
"EU/1/12/803/001"
]
}See everything about bromelains.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.